Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Nutrition in kidney diseases].

A Colombi1, R Martin

  • 1Nierenstation der Medizinischen Klinik, Kantonsspital Luzern.

Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|October 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modelling chase-and-run migration in heterogeneous populations.

Journal of mathematical biology·2019
Same author

Modelling human perception processes in pedestrian dynamics: a hybrid approach.

Royal Society open science·2017
Same author

Coherent modelling switch between pointwise and distributed representations of cell aggregates.

Journal of mathematical biology·2016
Same author

[Biological risk prevention in agriculture and animal breeding: immunization strategies].

Giornale italiano di medicina del lavoro ed ergonomia·2011
Same author

[The occupational health physician and the health surveillance in agriculture].

Giornale italiano di medicina del lavoro ed ergonomia·2011
Same author

Neurobehavioural effects of pesticides with special focus on organophosphorus compounds: which is the real size of the problem?

Neurotoxicology·2009
Same journal

[In Process Citation]

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1999
Same journal

[A case from practice (306). Erythema (chronicum) migrans (stage I of Lyme borreliosis].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
Same journal

[A case from practice (305). Recurrent erysipelas--tinea pedis et unginum--chronic venous insufficiency].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
Same journal

[Neuroendocrine tumors of the stomach (stomach carcinoid)].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
Same journal

[Time of drug intake in hypertension and angina pectoris. A controlled monitoring study].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
Same journal

[Mental suffering IN patients with parkinsonism].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
See all related articles

Dietary changes can slow chronic kidney disease progression. Key strategies include salt restriction for hypertension, protein intake control, and phosphate reduction with binders to manage phosphorus levels and bone health.

Area of Science:

  • Nephrology
  • Dietary Science
  • Internal Medicine

Context:

  • Chronic progressive renal failure (CPRF) management.
  • Hypertension as a comorbidity in renal disease.
  • Importance of metabolic balance in kidney disease.

Purpose:

  • To outline effective dietary strategies for managing chronic progressive renal failure.
  • To highlight the role of specific nutritional interventions in slowing disease progression and maintaining bone health.

Summary:

  • Salt restriction is crucial for hypertensive patients undergoing antihypertensive therapy.
  • Protein restriction (0.6 g/kg/day) slows renal disease progression, except in adult polycystic kidney disease.
  • Phosphate normalization via diet and binders is essential for slowing disease and preserving bone metabolism; Ketosteril can prevent essential amino acid deficiency.

Related Experiment Videos

Impact:

  • Provides evidence-based dietary guidelines for nephrologists and patients.
  • Aims to improve patient outcomes by slowing chronic kidney disease progression.
  • Contributes to better management of comorbidities and metabolic disturbances in renal failure.